SLC26A2 and skeletal dysplasia: Our Finnish pediatric cohort comprised 14 subjects with SLC26A2-related skeletal dysplasia; 75% of all subjects and 90% of those with the DTD phenotype were homozygous for the Finnish founder mutation and one was (compound) heterozygous for the founder mutation.